Vincristine-induced neuropathy in childhood all (acute lymphoblastic leukemia) survivors: Prevalence and electrophysiological characteristics

Journal of Child Neurology

Volumn 29, Issue 7, 2014, Pages 932-937

  Jain, Puneet ^a   Gulati, Sheffali ^a   Seth, Rachna ^a   Bakhshi, Sameer ^b   Toteja, G S ^c   Pandey, R M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c HalpAge India   (India)

Author keywords

Acute lymphoblastic leukemia; Pediatric cancer; Total neuropathy score; Vincristine induced peripheral neuropathy

Indexed keywords

VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL EVALUATION; COMPOUND MUSCLE ACTION POTENTIAL; CROSS-SECTIONAL STUDY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MONONEUROPATHY; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NEUROPATHY; PERONEUS NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; SCORING SYSTEM; SENSORY SYSTEM ELECTROPHYSIOLOGY; SENSORY SYSTEM EXAMINATION; SYMMETRIC MOTOR AXONAL POLYNEUROPATHY; TERTIARY CARE CENTER; TIBIAL NERVE; TOTAL NEUROPATHY SCORE; ULNAR NERVE; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTROPHYSIOLOGY; FEMALE; MALE; MORTALITY; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVOR;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CROSS-SECTIONAL STUDIES; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; SEVERITY OF ILLNESS INDEX; SURVIVORS; VINCRISTINE;

EID: 84903531253     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813491829     Document Type: Article

References (18)

1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371(9617):1030-1043.
2. Arya LS, Kotikanyadanam SP, Bhargava M, et al. Pattern of relapse in childhood ALL: challenges and lessons from a uniform treatment protocol. J Pediatr Hematol Oncol. 2010;32(5):370-375.
3. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27-46.
4. Kautio AL, Haanpaa M, Kautiainen H, et al. Burden of chemotherapy-induced neuropathy - a cross sectional study. Support Care Cancer. 2011; 19(12):1991-1996.
5. Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009;14(3):184-189.
6. Reinders-Messelink HA, Schoemaker MM, Snijders TAB, et al. Analysis of handwriting of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 2001;37(4):393-399.
7. Reinders-Messelink HA, Schoemaker MM, Snijders TAB, et al. Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1999;33(6):545-550.
8. Harila-Saari AH, Huuskonen UEJ, Tolonen U, et al. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials. Med Pediatr Oncol. 2001;36(3):345-351.
9. Hyllienmark L, Ludvigsson J, Brismar T. Normal values of nerve conduction in children and adolescents. Electroencephalogr Clin Neurophysiol. 1995;97(5):208-214.
10. Preston DC, Shapiro BE. Electromyography and Neuromuscular Disorders. Clinical-Electrophysiologic Correlations. 2nd ed. Philadelphia, PA: Elsevier; 2005.
11. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology. 1999;53(8): 1660-1664.
12. Cavaletti G, Jann S, Pace A, et al. Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2006;11(2):135-141.
13. Cavaletti G, Frigeni B, Lanzani F, et al. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapyinduced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst. 2007;12(3):210-215.
14. Sarris AH, Hagemeister F, Romaguera J, et al. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. Ann Oncol. 2000;11(1):69-72.
15. Brigo F, Balter R, Marradi P, et al. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia. J Child Neurol. 2012;27(7):867-874.
16. Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. Ind J Pediatr. 2010;77(1):97-100.
17. Chauvenet AR, Shashi V, Selsky C, et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 2003;25(4):316-320.
18. Reinders-Messelink HA, van Weerden TW, Fock JM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukemia. Eur J Pediatr Neurol. 2000;4(5):225-233.